Meanwhile, revenue is forecast to climb 2.3% year-over-year to $23.8 billion, benefitting from strong growth in its pharmaceuticals business, medical devices division, as well as its consumer staples health segment, which it plans to split into a new publicly-traded company next year. JNJ has topped Wall Street’s profit expectations in every quarter dating back to at least Q1 2013, as per InvestingPro+, highlighting the strength and resilience of its business. market open on Tuesday, July 19.Ĭonsensus calls for the New Brunswick, New Jersey-based company to post earnings per share of $2.55 for the second quarter, improving 2.8% from EPS of $2.48 in the year-ago period. Johnson & Johnson (NYSE: JNJ) could see increased buying activity in the days ahead as the healthcare conglomerate is expected to deliver a beat on earnings and revenue growth when it releases its latest financial results ahead of the U.S.
Remember though, our timeframe is just for the upcoming week. Regardless of which direction the market goes, below we highlight one stock likely to be in demand and another which could see further downside. The Philadelphia Fed manufacturing survey and latest PMI prints will also be released.
On the economic calendar, the focus turns to housing with the latest updates on housing starts, building permits, and existing home sales for the month of June. The week ahead is expected to be another eventful one as Q2 earnings shift into high gear, with reports expected from notable names from a wide range of industries, including Tesla (NASDAQ: TSLA), Netflix (NASDAQ: NFLX), Twitter (NYSE: TWTR), IBM (NYSE: IBM), Bank of America (NYSE: BAC), Goldman Sachs (NYSE: GS), American Express (NYSE: AXP), AT&T Inc (NYSE: T), Verizon (NYSE: VZ), as well as United Airlines Holdings Inc (NASDAQ: UAL), and American Airlines (NASDAQ: AAL).
0 kommentar(er)
